News

The company is a part of the EU-funded project SEtTReND (Schistosoma Epigenetics – Targets, Regulation, New Drugs) with major focus on drug discovery, dddmag.com reported. The project involves

As per the license agreenent signed between the two companies in 2004 agreement, they will share all data and associated know-how of the MN-221 development program. MN-221 is

The lawsuit was registered for submission of an abbreviated new drug application (ANDA) to the US Food and Drug Administration’s (FDA) prior to the expiration of Noven’s patents

Humana’s experience in health care and Pfizer’s expertise in researching and developing medicines will bring together data and scientific information to better understand patient needs and the effectiveness

According to the company, it is all set to release its first set of Cannabis Science brand formulations through its producing lab and initial Colorado State licensed dispensary.

The deal comprises development of generic pharmaceutical products by Micro Labs, moneyweb.co.za reported. moneyweb.co.za quoted Litha Healthcare Group CEO Selwyn Kahanovitz saying that the agreement would help them

The companies intend to establish themselves in the fields of production, marketing and distribution of pharmaceutical products in Russia, inpharm.com reported. The UPC which is a complex of

The compound has been discovered by the company’s Artificial Intelligence drug discovery process, CHEMSAS. The specific cellular targeting, low toxicity, and efficacy of the drug candidate help in

Injectafer is a non-dextran intravenous iron (i.v.) replacement therapy containing ferric carboxymaltose as its active pharmaceutical ingredient. The NDA includes the data from two randomized controlled clinical trials